4basebio PLC · LSE:4BB
Elevage Medical Technologies Holdings, LLC (as indirect parent shareholder under DTR 5.1.2 and 5.2.1(e) and indirect holder of voting rights under DTR 5.2.1(a))'s stake in 4basebio PLC fell to 27.80% (TR-1 holding notification)
Event Nov 10, 2026 · Filed Nov 12, 2026
Elevage Medical Technologies Holdings, LLC (as indirect parent shareholder under DTR 5.1.2 and 5.2.1(e) and indirect holder of voting rights under DTR 5.2.1(a))'s stake in 4basebio PLC fell to 27.80%, 5,350,075 shares on Nov 10, 2026. Filed Nov 12, 2026 (TR-1 holding notification).
- Stake
- 27.80%
- Shares
- 5,350,075
- What changed
- Fell below 28%
The filing in full
TR-1: Standard form for notification of major holdings
| NOTIFICATION OF MAJOR HOLDINGS(to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i | ||||
|---|---|---|---|---|
| 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: | 4basebio PLC | |||
| 1b. Please indicate if the issuer is a non-UK issuer(please mark with an “X” if appropriate) | ||||
| Non-UK issuer | ||||
| 2\. Reason for the notification(please mark the appropriate box or boxes with an “X”) | ||||
| An acquisition or disposal of voting rights | X | |||
| An acquisition or disposal of financial instruments | ||||
| An event changing the breakdown of voting rights | X | |||
| Other (please specify) iii: | ||||
| 3\. Details of person subject to the notification obligationiv | ||||
| Name | Elevage Medical Technologies Holdings, LLC (as indirect parent shareholder under DTR 5.1.2 and 5.2.1(e) and indirect holder of voting rights under DTR 5.2.1(a)) | |||
| City and country of registered office (if applicable) | Wilmington, Delaware, United States | |||
| 4\. Full name of shareholder(s) (if different from 3.) v | ||||
| Name | Fort Aggregator, LP (as direct shareholder) and the Prudential Assurance Company Limited (as the other party to the agreement under DTR5.2.1(a)) | |||
| City and country of registered office (if applicable) | 1. Fort Aggregator, LP: Wilmington, Delaware, United States2. Prudential Assurance Company Limited: London, United Kingdom | |||
| 5\. Date on which the threshold was crossed or reachedvi: | 10 November 2026 | |||
| 6\. Date on which issuer notified (DD/MM/YYYY): | 11 November 2026 | |||
| 7\. Total positions of person(s) subject to the notification obligation | ||||
| % of voting rights attached to shares (total of 8. A) | % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) | Total of both in % (8.A + 8.B) | Total number of voting rights held in issuer (8.A + 8.B) vii | |
| Resulting situation on the date on which threshold was crossed or reached | 27.8% | 0 | 27.8% | 5,350,075 |
| Position of previous notification (if applicable) | 29.9% | 0 | 29.9% | 4,627,741 |
| 8\. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii | |||||
|---|---|---|---|---|---|
| A: Voting rights attached to shares | |||||
| Class/type ofsharesISIN code (if possible) | Number of voting rightsix | % of voting rights | |||
| Direct(DTR5.1) | Indirect(DTR5.2.1) | Direct(DTR5.1) | Indirect(DTR5.2.1) | ||
| Ordinary shares of €1.00 each under DTR 5.2.1(e)ISIN: GB00BMCLYF79 | 0 | 2,923,171 | 0 | 15.2% | |
| Ordinary shares of €1.00 each under DTR 5.2.1(a)ISIN: GB00BMCLYF79 | 0 | 2,426,904 | 0 | 12.6% | |
| SUBTOTAL 8. A | 5,350,075 | 27.8% | |||
| B 1: Financial Instruments according to DTR5.3.1R (1) (a) | |||||
| Type of financial instrument | Expirationdatex | Exercise/Conversion Periodxi | Number of voting rights that may be acquired if the instrument isexercised/converted. | % of voting rights | |
| SUBTOTAL 8. B 1 | |||||
| B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b) | |||||
| Type of financial instrument | Expirationdatex | Exercise/Conversion Periodxi | Physical or cashSettlementxii | Number of voting rights | % of voting rights |
| SUBTOTAL 8.B.2 |
| 9\. Information in relation to the person subject to the notification obligation(please mark the applicable box with an “X”) | |||
|---|---|---|---|
| Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii | |||
| Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv | X | ||
| Namexv | % of voting rights if it equals or is higher than the notifiable threshold | % of voting rights through financial instruments if it equals or is higher than the notifiable threshold | Total of both if it equals or is higher than the notifiable threshold |
| Chain 1 in respect of Fort Aggregator, LP: | |||
| Elevage Medical Technologies Holdings, LLC | 15.2% | 15.2% | |
| Elevage Medical Technologies GP, LLC | 15.2% | 15.2% | |
| Fort Aggregator, LP | 15.2% | 15.2% | |
| Chain 2 in respect of the Prudential Assurance Company Limited | |||
| M&G plc | 12.6% | 12.6% | |
| M&G Group Regulated Entity Holding Company Limited | 12.6% | 12.6% | |
| M&G Group Limited | 12.6% | 12.6% | |
| M&G FA Limited | 12.6% | 12.6% | |
| M&G Investment Management Limited | 12.6% | 12.6% | |
| 10\.In case of proxy voting, please identify: | |||
| Name of the proxy holder | |||
| The number and % of voting rights held | |||
| The date until which the voting rights will be held | |||
| 11\. Additional informationxvi | |||
| Fort Aggregator, LP and the Prudential Assurance Company Limited are acting in concert pursuant to DTR 5.2.1(a). As such, the disclosure in sections 7, 8 and 9 of this form reflects their aggregated position. A separate notification will be made on behalf of M&G plc in respect of the Prudential Assurance Company Limited’s shareholding. |
| Place of completion | Wilmington, Delaware, United States |
|---|---|
| Date of completion | 11 November 2026 |
- * *
- * *
| Holder | Stake | Shares |
|---|---|---|
| Elevage Medical Technologies Holdings, LLC (as indirect parent shareholder under DTR 5.1.2 and 5.2.1(e) and indirect holder of voting rights under DTR 5.2.1(a)) | 27.80% | 5,350,075 |
Source
Download original · View original at FCA
Related
- 4basebio PLC
- Elevage Medical Technologies Holdings, LLC (as indirect parent shareholder under DTR 5.1.2 and 5.2.1(e) and indirect holder of voting rights under DTR 5.2.1(a))
- 4basebio PLC shareholders
- TR-1 holding notification · Wilhelm K. T. Zours · Nov 17, 2026
- TR-1 holding notification · Wilhelm K. T. Zours · Nov 13, 2026
- TR-1 holding notification · Aberdeen Group plc · Nov 12, 2026
- TR-1 holding notification · M&G plc (as indirect parent shareholder under DTR 5.1.2 and 5.2.1(e) and indirect holder of voting rights under DTR 5.2.1(a)) · Nov 12, 2026